Efficacy of Therapeutic Exercise Compared to Femoral Nerve Mobilisation in Knee Tendinosis

NCT06569433 | Not Yet Recruiting DMC

• 1 other identifier: Silvia M
• Study Type: interventional
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

Tendons, located between muscle and bone, transmit force from the former to the latter, allowing joint movement. They are composed mainly of collagen, elastin and water, and are divided into three zones: osteotendinous junction (tendon-bone), myotendinous junction (muscle-tendon) and the tendon body. Knee tendinosis is a pathology that affects the tendons of this joint due to the breakdown of collagen in the tendon body, characterised by pain during and after exercise, inflammation and loss of function. It is common in athletes, especially in jumping sports such as basketball and volleyball, due to repetitive strain, injury or ageing. Factors such as weight, leg length and muscle strength can influence its development. Radiologically, patellar tendon thickening, and abnormalities are seen. Treatment includes eccentric exercises, shock wave therapy, ultrasound-guided sclerosis, anti-inflammatory drugs, plasma injections and aprotinin. Neurodynamic theory suggests that altered mechanosensitivity of the femoral nerve may contribute to knee pain, and neurodynamic techniques can improve nerve mobility and reduce symptoms. A strength exercise with isometric contractions can decrease pain for up to 45 minutes, being a therapeutic option for patellar tendinopathy without affecting muscle strength. The research project presented in the master's thesis aims to compare the effectiveness of femoral nerve mobilisation and therapeutic exercise in the treatment of knee tendinosis.

Conditions

Chronic Patellar Tendinopathy

Outcome Measures

Primary Outcomes (2)

• The 'pain' variable

  The variable 'pain' is subjective and qualitative and is measured quantitatively to facilitate its analysis. In this case the Visual Analogue Scale (VAS) will be used, which facilitates the subjective evaluation of the intensity of the pain that the patient experiences, through a score based on their perception of pain, It ranges from 0 (being the lowest score therefore there is no pain) to 10 (being the highest score therefore it is at its maximum pain level)

  6 weeks

• functionality (VISA-P questionnaire)

  the VISA-P questionnaire which allows us to classify tendinopathy according to the severity of the symptoms and the functional capacity of the patients.

  6 weeks

Study Arms (2)

Therapeutic exercise

ACTIVE COMPARATOR

In the interventions, the control group performing therapeutic exercise only, will perform a specific exercise programme for knee tendinitis under the supervision of a physiotherapist,

Procedure: THERAPEUTIC EXERCISE AND MOBILISATION OF THE FEMORAL NERVE

Femoral nerve movilization

ACTIVE COMPARATOR

will receive therapeutic exercise sessions and femoral nerve mobilisations performed by a trained physiotherapist.

Procedure: THERAPEUTIC EXERCISE AND MOBILISATION OF THE FEMORAL NERVE

Interventions

THERAPEUTIC EXERCISE AND MOBILISATION OF THE FEMORAL NERVE PROCEDURE

the control group that will perform only therapeutic exercise will perform a specific exercise programme for knee tendinitis under the supervision of a physiotherapist, while the intervention group that will perform therapeutic exercise plus femoral nerve mobilisation will receive therapeutic exercise sessions and femoral nerve mobilisations performed by a trained physiotherapist. The intervention will last for 6 weeks, during which 60-minute sessions will be held at the centre, measurements will be taken during the six weeks, using standardised questionnaires to evaluate the variables (set out below) and always measuring the range of movement and femoral nerve mobility with the Slump Test on the same day of the week and at the same time of treatment.

Femoral nerve movilization; Therapeutic exercise

Eligibility Criteria

• Age: 18 Years - 40 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• \- Patients aged 18 to 40 years old
• Patients with chronic or acute knee tendinosis
• Who have pain or functional limitation

You may not qualify if:

• Patients with a contraindication to treatment
• Patients with a history of recent knee surgery or serious injury
• Who present neurological pathologies
• Who are using other physiotherapy techniques

Sponsors & Collaborators

• University of Alcala: lead

MeSH Terms

Interventions

Exercise Therapy

Intervention Hierarchy (Ancestors)

Rehabilitation; Aftercare; Continuity of Patient Care; Patient Care; Therapeutics; Physical Therapy Modalities

Central Study Contacts

Silvia Martinez

CONTACT

626705563; silvia.martinezv@edu.uah.es

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Investigador principal

Model Details: The following criteria for inclusion and exclusion of participants have been established: Inclusion criteria: * Patients aged between 18 and 40 years. * Patients with chronic or acute knee tendinosis. * Patients with pain or functional limitation Exclusion criteria: * Patients with any contraindication to treatment. * Patients with a history of recent knee surgery or serious injury * Who present neurological pathologies * Who are using other physiotherapy techniques Prior to registration each participant must undergo a physical assessment, including a medical history check and provide information on neurological and trauma pathologies. Those who meet the criteria will be assigned to one of the two study groups.

Study Record Dates

• First Submitted: August 11, 2024
• First Posted: August 26, 2024
• Study Start: August 20, 2024
• Primary Completion: September 20, 2024
• Study Completion: December 20, 2024
• Last Updated: August 26, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share